Costs of Nonoperative Procedures for Knee Osteoarthritis in the Year Prior to Primary Total Knee Arthroplasty. (5th October 2022)
- Record Type:
- Journal Article
- Title:
- Costs of Nonoperative Procedures for Knee Osteoarthritis in the Year Prior to Primary Total Knee Arthroplasty. (5th October 2022)
- Main Title:
- Costs of Nonoperative Procedures for Knee Osteoarthritis in the Year Prior to Primary Total Knee Arthroplasty
- Authors:
- Nin, Darren Z.
Chen, Ya-Wen
Talmo, Carl T.
Hollenbeck, Brian L.
Mattingly, David A.
Niu, Ruijia
Chang, David C.
Smith, Eric L. - Abstract:
- Abstract : Background: The convergence of national priorities to reduce health-care costs and deliver high-value care warrants the need to examine health-care utilization. The objective of this study was to describe the costs associated with nonoperative procedures in the 1-year period leading up to primary total knee arthroplasty (TKA). Methods: An observational cohort study was conducted using the IBM Watson Health MarketScan databases. Patients with late-stage knee osteoarthritis (OA) who underwent unilateral, isolated primary TKA from January 1, 2018, to December 31, 2019, were included. The main outcome was the cost of knee OA-related payments for identified nonoperative procedures in the 1-year period before surgery. Nonoperative procedures examined were (1) physical therapy (PT); (2) bracing; (3) intra-articular injections: professional fee, hyaluronic acid (IA-HA), and corticosteroids (IA-CS); (4) medication: nonsteroidal anti-inflammatory drugs (NSAIDs), opioids, and acetaminophen; and (5) knee-specific imaging. Results: The study population included 24, 492 TKA patients with a mean age of 60.4 ± 8.0 years. The average total cost of nonoperative procedures per patient was $1, 355 ± $2, 087. The most common nonoperative treatment prescribed was IA-CS (54.3%). The nonoperative procedure with the highest cost per patient was IA-HA ($1, 019 ± $913 per patient). The total cost of nonoperative procedures was higher among female compared with male patients ($1, 440 ± $2,Abstract : Background: The convergence of national priorities to reduce health-care costs and deliver high-value care warrants the need to examine health-care utilization. The objective of this study was to describe the costs associated with nonoperative procedures in the 1-year period leading up to primary total knee arthroplasty (TKA). Methods: An observational cohort study was conducted using the IBM Watson Health MarketScan databases. Patients with late-stage knee osteoarthritis (OA) who underwent unilateral, isolated primary TKA from January 1, 2018, to December 31, 2019, were included. The main outcome was the cost of knee OA-related payments for identified nonoperative procedures in the 1-year period before surgery. Nonoperative procedures examined were (1) physical therapy (PT); (2) bracing; (3) intra-articular injections: professional fee, hyaluronic acid (IA-HA), and corticosteroids (IA-CS); (4) medication: nonsteroidal anti-inflammatory drugs (NSAIDs), opioids, and acetaminophen; and (5) knee-specific imaging. Results: The study population included 24, 492 TKA patients with a mean age of 60.4 ± 8.0 years. The average total cost of nonoperative procedures per patient was $1, 355 ± $2, 087. The most common nonoperative treatment prescribed was IA-CS (54.3%). The nonoperative procedure with the highest cost per patient was IA-HA ($1, 019 ± $913 per patient). The total cost of nonoperative procedures was higher among female compared with male patients ($1, 440 ± $2, 159 versus $1, 254 ± $1, 992 per patient; p < 0.01). The highest costs were found for patients in the Northeast ($1, 740 ± $2, 437 per patient). A total of 14, 346 (58.6%) and 7, 831 (32.0%) of the patients had >1 and ≥3 nonoperative treatments, respectively. Conclusions: There is substantial variation in the type and the cost of nonoperative treatment for patients with late-stage OA. Future studies should investigate the effectiveness of nonoperative treatments at different stages of the disease. Level of Evidence: Therapeutic Level III . See Instructions for Authors for a complete description of levels of evidence. … (more)
- Is Part Of:
- Journal of bone and joint surgery. Volume 104:Number 19(2022)
- Journal:
- Journal of bone and joint surgery
- Issue:
- Volume 104:Number 19(2022)
- Issue Display:
- Volume 104, Issue 19 (2022)
- Year:
- 2022
- Volume:
- 104
- Issue:
- 19
- Issue Sort Value:
- 2022-0104-0019-0000
- Page Start:
- 1697
- Page End:
- 1702
- Publication Date:
- 2022-10-05
- Subjects:
- Bones -- Surgery -- Periodicals
Joints -- Surgery -- Periodicals
Orthopedics -- Periodicals
Orthopedics
General Surgery
Bone Diseases
Joint Diseases
Bones -- Surgery
Joints -- Surgery
Orthopedics
Bot (anatomie)
Gewrichten
Chirurgie (geneeskunde)
Periodicals
Electronic journals
Periodicals
617.47005 - Journal URLs:
- http://www.clinicalkey.com/dura/browse/journalIssue/00219355 ↗
http://www.clinicalkey.com.au/dura/browse/journalIssue/00219355 ↗
http://www.ejbjs.org/contents-by-date.0.dtl ↗
http://gateway.ovid.com/ovidweb.cgi?T=JS&PAGE=toc&D=ovft&MODE=ovid&NEWS=N&AN=00002060-000000000-00000 ↗
http://journals.lww.com/pages/default.aspx ↗ - DOI:
- 10.2106/JBJS.21.01415 ↗
- Languages:
- English
- ISSNs:
- 0021-9355
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 4954.250000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 24134.xml